Integrating Multimodal Data and Genomics for a Comprehensive Assessment of Cardiovascular Aging and Its Impact
Adila Abula1, Yuxin Yuan2, Xiaoyu Li3
1Center of Clinical Big Data and Analytics of The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China; Institute of Digital and Intelligent Health, Zhejiang University, Hangzhou, Zhejiang, China.
Background:
Age-related structural and functional remodeling of the heart and vessels increases cardiovascular disease (CVD) risk, yet comprehensive assessments using multimodal imaging and genetic characterization remains limited. We aimed to quantify cardiovascular aging using multimodal biomarkers and evaluate its genetic architecture, lifestyle determinants, and prognostic relevance.
Methods:
From the UK biobank, cardiovascular magnetic resonance (CMR), electrocardiogram, arterial stiffness, and carotid ultrasound biomarkers were integrated to establish a cardiovascular aging measure using machine learning (ML) models. Seven ML models were evaluated to predict cardiovascular age, and cardiovascular age gap (CardioAG) was calculated using the best-performing model. Associations between CardioAG and incident CVD outcomes were assessed, alongside modality-specific analyses to evaluate the incremental value of multimodal integration. Whole-genome sequencing (WGS) analyses were conducted to identify genetic variants associated with CardioAG, and linear regression models were applied to examine relationships between CardioAG and key lifestyle factors.
Results:
Among 22,452 participants with complete multimodal data, 13,694 individuals free of baseline CVDs (median age 62.6 years [IQR 56.5-68.3], median follow-up 4.8 years [IQR 3.7-6.3]) were selected for model development. With 57 cardiovascular aging biomarkers, the CatBoost model performed best on the test dataset (Pearson r = 0.75; mean absolute error = 3.88 years). CardioAG was independently associated with hypertension, stroke, atrial fibrillation, coronary artery disease, and composite major adverse cardiovascular event (MACE, hazard ratio = 1.08, 95% CI, 1.06-1.10). Incremental and ablation analyses demonstrated complementary contributions across imaging and functional modalities, with multimodal integration enhancing predictive accuracy and providing independent prognostic value for MACE. WGS analysis identified novel common genetic variants associated with interindividual variability in CardioAG, including RN7SKP155, SVIL, and CBFA2T3, highlighting genetic contributions to vascular remodeling, electrophysiological and hemodynamic regulation, and cardiovascular functional reserve. Dietary factors, sleep duration, physical activity level, smoking, and alcohol intake were found to be significantly associated with CardioAG.
Conclusions:
This study developed a unified multimodal cardiovascular aging metric that integrates cardiac structure and function, vascular remodeling and stiffness, and electrophysiological features into a single biologically grounded, cumulative aging signal, providing incremental prognostic utility for CVD, and broadening the biological and genetic landscape underlying cardiovascular aging.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System IV: CMRI
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...

